Literature DB >> 19506816

Response of an adult patient with pineoblastoma to vorinostat and retinoic acid.

Rebecca DeBoer1, Hunt Batjer2, Maryanne Marymont3, Stewart Goldman4, Matthew Walker5, Numa Gottardi-Littell6, Jeffrey Raizer7.   

Abstract

We report the case of an adult patient with pineoblastoma (PBL) who had a complete radiographic response following treatment with vorinostat and retinoic acid. This regimen was used to treat bulky residual tumor that persisted despite radiation therapy (RT) and two cycles of cytotoxic chemotherapy. Vorinostat and retinoic acid were chosen as an alternative to cytotoxic chemotherapy, which our patient was unable to tolerate, based on preclinical data suggesting efficacy of this combination. MRI demonstrated a complete response to this regimen, which continues to remain stable without evidence of recurrence.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19506816     DOI: 10.1007/s11060-009-9921-5

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  9 in total

1.  Histone deacetylase inhibitors induce cell death in supratentorial primitive neuroectodermal tumor cells.

Authors:  K Saravana Kumar; Jürgen Sonnemann; James F Beck
Journal:  Oncol Rep       Date:  2006-11       Impact factor: 3.906

2.  Suberoylanilide hydroxamic acid is effective in preclinical studies of medulloblastoma.

Authors:  Susan E Spiller; Ali C Ravanpay; Andrew W Hahn; James M Olson
Journal:  J Neurooncol       Date:  2006-04-28       Impact factor: 4.130

Review 3.  Discovery and development of SAHA as an anticancer agent.

Authors:  P A Marks
Journal:  Oncogene       Date:  2007-02-26       Impact factor: 9.867

4.  High-dose chemotherapy with autologous stem-cell rescue in children and adults with newly diagnosed pineoblastomas.

Authors:  Sridharan Gururangan; Colleen McLaughlin; Jennifer Quinn; Jeremy Rich; David Reardon; Edward C Halperin; James Herndon; Herbert Fuchs; Timothy George; James Provenzale; Melody Watral; Roger E McLendon; Allan Friedman; Henry S Friedman; Joanne Kurtzberg; James Vredenbergh; Paul L Martin
Journal:  J Clin Oncol       Date:  2003-06-01       Impact factor: 44.544

5.  Pineoblastoma in adults.

Authors:  S M Chang; P K Lillis-Hearne; D A Larson; W M Wara; A W Bollen; M D Prados
Journal:  Neurosurgery       Date:  1995-09       Impact factor: 4.654

6.  Response of preclinical medulloblastoma models to combination therapy with 13-cis retinoic acid and suberoylanilide hydroxamic acid (SAHA).

Authors:  Susan E Spiller; Sally H Ditzler; Barbara J Pullar; James M Olson
Journal:  J Neurooncol       Date:  2007-12-05       Impact factor: 4.130

7.  Histone deacetylase inhibitors induce cell death and enhance the susceptibility to ionizing radiation, etoposide, and TRAIL in medulloblastoma cells.

Authors:  Jürgen Sonnemann; K Saravana Kumar; Sandra Heesch; Cornelia Müller; Christoph Hartwig; Manfred Maass; Peter Bader; James F Beck
Journal:  Int J Oncol       Date:  2006-03       Impact factor: 5.650

Review 8.  Histone deacetylase inhibitors: molecular mechanisms of action.

Authors:  W S Xu; R B Parmigiani; P A Marks
Journal:  Oncogene       Date:  2007-08-13       Impact factor: 9.867

Review 9.  Malignant pineal parenchymal tumors in adult patients: patterns of care and prognostic factors.

Authors:  Johannes Lutterbach; François Fauchon; Steven E Schild; Susan M Chang; Axel Pagenstecher; Benedikt Volk; Christoph Ostertag; Felix Momm; Anne Jouvet
Journal:  Neurosurgery       Date:  2002-07       Impact factor: 4.654

  9 in total
  2 in total

1.  Complete regression of adult pineoblastoma following radiotherapy: A case report and review of the literature.

Authors:  Ping Ai; Xingchen Peng; Yong Jiang; Hong Zhang; Shichao Wang; Yuquan Wei
Journal:  Oncol Lett       Date:  2015-08-04       Impact factor: 2.967

Review 2.  Targeting of histone deacetylases in brain tumors.

Authors:  Jonas Ecker; Olaf Witt; Till Milde
Journal:  CNS Oncol       Date:  2013-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.